PMID: 2486541Nov 1, 1989Paper

Hyperlipidemia of nephrosis: pathophysiologic role in progressive glomerular disease

The American Journal of Medicine
J R Diamond

Abstract

During the past few years, the increasing speculation that the hyperlipidemia of nephrosis may be one of several pathogenic mechanisms involved in the progression of initial glomerular injury to glomerulosclerosis has generated many clinical and experimental investigations. This discussion reviews pertinent studies that address two major issues. First, the underlying pathophysiologic mechanisms involved in the development of the hyperlipidemia of nephrosis are explored. Second, this article examines recent studies that investigate how this secondary hyperlipidemia may further aggravate initial glomerular injury and contribute to a progressive glomerulopathy, primarily mediated through alterations in monocyte/macrophage function.

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Zhang-xue HuSong-min Huang
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Miguel F Palma DiazKelly D Smith
Current Opinion in Nephrology and Hypertension
J Kaplan, M R Pollak
© 2022 Meta ULC. All rights reserved